

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of histone deacetylation (GO:0031065) | 4.29584409 |
| 2 | peptidyl-lysine dimethylation (GO:0018027) | 4.12542341 |
| 3 | negative regulation of cell size (GO:0045792) | 3.83800269 |
| 4 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.70808230 |
| 5 | pre-miRNA processing (GO:0031054) | 3.65899510 |
| 6 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.48545618 |
| 7 | plasma membrane repair (GO:0001778) | 3.40147046 |
| 8 | negative regulation of cell killing (GO:0031342) | 3.39095035 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.39095035 |
| 10 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.17432011 |
| 11 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.16429084 |
| 12 | response to muramyl dipeptide (GO:0032495) | 3.13793441 |
| 13 | adherens junction assembly (GO:0034333) | 3.13448224 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.12275099 |
| 15 | response to laminar fluid shear stress (GO:0034616) | 3.11544258 |
| 16 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.09017504 |
| 17 | regulation of hippo signaling (GO:0035330) | 3.07331932 |
| 18 | heterochromatin organization (GO:0070828) | 3.07049493 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.06255184 |
| 20 | embryonic process involved in female pregnancy (GO:0060136) | 3.02619405 |
| 21 | focal adhesion assembly (GO:0048041) | 3.01054728 |
| 22 | cell-substrate adherens junction assembly (GO:0007045) | 3.01054728 |
| 23 | histone H3-K9 demethylation (GO:0033169) | 2.99751239 |
| 24 | positive thymic T cell selection (GO:0045059) | 2.96672734 |
| 25 | NLS-bearing protein import into nucleus (GO:0006607) | 2.94643822 |
| 26 | carnitine shuttle (GO:0006853) | 2.93011977 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.92047961 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.92047961 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.92047961 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 2.92047961 |
| 31 | positive regulation by symbiont of host defense response (GO:0052509) | 2.92047961 |
| 32 | modulation by symbiont of host defense response (GO:0052031) | 2.92047961 |
| 33 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.90260296 |
| 34 | negative regulation of histone methylation (GO:0031061) | 2.89966339 |
| 35 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.88572958 |
| 36 | negative regulation of myotube differentiation (GO:0010832) | 2.88079360 |
| 37 | positive regulation of protein deacetylation (GO:0090312) | 2.87718282 |
| 38 | cell-substrate junction assembly (GO:0007044) | 2.86351733 |
| 39 | histone H3-K36 demethylation (GO:0070544) | 2.84899967 |
| 40 | growth hormone receptor signaling pathway (GO:0060396) | 2.84785432 |
| 41 | negative regulation of fatty acid transport (GO:2000192) | 2.84230933 |
| 42 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.83518102 |
| 43 | germinal center formation (GO:0002467) | 2.83517497 |
| 44 | sodium ion export (GO:0071436) | 2.82933542 |
| 45 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.82630645 |
| 46 | regulation of cholesterol homeostasis (GO:2000188) | 2.82315266 |
| 47 | regulation of ARF protein signal transduction (GO:0032012) | 2.82015121 |
| 48 | apoptotic cell clearance (GO:0043277) | 2.81578824 |
| 49 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.80167736 |
| 50 | regulation of chromatin binding (GO:0035561) | 2.79964353 |
| 51 | regulation of early endosome to late endosome transport (GO:2000641) | 2.79385802 |
| 52 | negative regulation of necroptotic process (GO:0060546) | 2.79355311 |
| 53 | barbed-end actin filament capping (GO:0051016) | 2.78362323 |
| 54 | regulation of necroptotic process (GO:0060544) | 2.77925593 |
| 55 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.76647803 |
| 56 | positive regulation of nuclease activity (GO:0032075) | 2.76198722 |
| 57 | cellular response to growth hormone stimulus (GO:0071378) | 2.76020297 |
| 58 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.73928370 |
| 59 | mRNA stabilization (GO:0048255) | 2.73808435 |
| 60 | RNA stabilization (GO:0043489) | 2.73808435 |
| 61 | cardiac myofibril assembly (GO:0055003) | 2.73463054 |
| 62 | regulation of p38MAPK cascade (GO:1900744) | 2.73278160 |
| 63 | regulation of translational termination (GO:0006449) | 2.72726320 |
| 64 | gene silencing (GO:0016458) | 2.71972703 |
| 65 | gene silencing by RNA (GO:0031047) | 2.71102746 |
| 66 | detection of other organism (GO:0098543) | 2.69685755 |
| 67 | macroautophagy (GO:0016236) | 2.69473207 |
| 68 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.69262659 |
| 69 | positive regulation of myotube differentiation (GO:0010831) | 2.69125105 |
| 70 | regulation of gamma-delta T cell activation (GO:0046643) | 2.68970368 |
| 71 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.68691146 |
| 72 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.67261690 |
| 73 | regulation of histone H3-K27 methylation (GO:0061085) | 2.66940340 |
| 74 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.65622972 |
| 75 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.64409348 |
| 76 | response to peptidoglycan (GO:0032494) | 2.63733053 |
| 77 | detection of bacterium (GO:0016045) | 2.63697980 |
| 78 | positive regulation of RNA splicing (GO:0033120) | 2.63381823 |
| 79 | NIK/NF-kappaB signaling (GO:0038061) | 2.62882380 |
| 80 | mannose metabolic process (GO:0006013) | 2.62642197 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.62542548 |
| 82 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.62128046 |
| 83 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.60389720 |
| 84 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.60098980 |
| 85 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.59935594 |
| 86 | maternal placenta development (GO:0001893) | 2.58865328 |
| 87 | negative regulation of heart growth (GO:0061117) | 2.57323864 |
| 88 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.57323864 |
| 89 | nuclear pore complex assembly (GO:0051292) | 2.56880193 |
| 90 | fatty acid transmembrane transport (GO:1902001) | 2.56714155 |
| 91 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.54508327 |
| 92 | modulation by symbiont of host cellular process (GO:0044068) | 2.54385311 |
| 93 | regulation of cholesterol storage (GO:0010885) | 2.54170706 |
| 94 | synaptonemal complex assembly (GO:0007130) | 2.53868199 |
| 95 | histone H4 deacetylation (GO:0070933) | 2.53141782 |
| 96 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.52124119 |
| 97 | activation of Rac GTPase activity (GO:0032863) | 2.51365803 |
| 98 | stress fiber assembly (GO:0043149) | 2.51360692 |
| 99 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.51262073 |
| 100 | cellular hyperosmotic response (GO:0071474) | 2.50633557 |
| 101 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.49285197 |
| 102 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.49285197 |
| 103 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.48990350 |
| 104 | pinocytosis (GO:0006907) | 2.48349804 |
| 105 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.48127604 |
| 106 | proline biosynthetic process (GO:0006561) | 2.47315615 |
| 107 | regulation of nuclease activity (GO:0032069) | 2.46840918 |
| 108 | pentose-phosphate shunt (GO:0006098) | 2.46582429 |
| 109 | macrophage activation involved in immune response (GO:0002281) | 2.46416910 |
| 110 | regulation of fatty acid oxidation (GO:0046320) | 2.43635098 |
| 111 | natural killer cell differentiation (GO:0001779) | 2.42202069 |
| 112 | protein localization to endosome (GO:0036010) | 2.42071758 |
| 113 | tricarboxylic acid metabolic process (GO:0072350) | 2.41777359 |
| 114 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.41417794 |
| 115 | creatine metabolic process (GO:0006600) | 2.41072932 |
| 116 | regulation of RNA export from nucleus (GO:0046831) | 2.40350427 |
| 117 | fibroblast migration (GO:0010761) | 2.40041615 |
| 118 | 2-oxoglutarate metabolic process (GO:0006103) | 2.39636481 |
| 119 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.39277041 |
| 120 | histone H2A monoubiquitination (GO:0035518) | 2.39140419 |
| 121 | COPI coating of Golgi vesicle (GO:0048205) | 2.38997014 |
| 122 | Golgi transport vesicle coating (GO:0048200) | 2.38997014 |
| 123 | T cell selection (GO:0045058) | 2.38518557 |
| 124 | cellular extravasation (GO:0045123) | 2.38369228 |
| 125 | histone lysine demethylation (GO:0070076) | 2.37405561 |
| 126 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.37162670 |
| 127 | modulation by virus of host process (GO:0019054) | 2.37072543 |
| 128 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.36974963 |
| 129 | negative thymic T cell selection (GO:0045060) | 2.36666173 |
| 130 | positive regulation of p38MAPK cascade (GO:1900745) | 2.36618142 |
| 131 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.35084807 |
| 132 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.34993215 |
| 133 | negative regulation of viral release from host cell (GO:1902187) | 2.34874112 |
| 134 | regulation of translational fidelity (GO:0006450) | 2.34582956 |
| 135 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.34438313 |
| 136 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.34146238 |
| 137 | regulation of ARF GTPase activity (GO:0032312) | 2.33972266 |
| 138 | NADH metabolic process (GO:0006734) | 2.33702865 |
| 139 | stress granule assembly (GO:0034063) | 2.33633009 |
| 140 | signal complex assembly (GO:0007172) | 2.33047524 |
| 141 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.32931791 |
| 142 | dosage compensation (GO:0007549) | 2.32322960 |
| 143 | regulation of leukocyte degranulation (GO:0043300) | 2.31558972 |
| 144 | B cell receptor signaling pathway (GO:0050853) | 2.30801500 |
| 145 | carnitine transmembrane transport (GO:1902603) | 2.30332648 |
| 146 | detection of external biotic stimulus (GO:0098581) | 2.30207590 |
| 147 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.30078744 |
| 148 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.29878870 |
| 149 | histone H4-K16 acetylation (GO:0043984) | 2.29826017 |
| 150 | epithelial cell-cell adhesion (GO:0090136) | 2.29769395 |
| 151 | low-density lipoprotein particle clearance (GO:0034383) | 2.29515485 |
| 152 | sarcomere organization (GO:0045214) | 2.29328754 |
| 153 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.29277539 |
| 154 | glial cell proliferation (GO:0014009) | 2.28616314 |
| 155 | histone demethylation (GO:0016577) | 2.28233133 |
| 156 | nuclear pore organization (GO:0006999) | 2.28007497 |
| 157 | positive regulation of receptor recycling (GO:0001921) | 2.27967447 |
| 158 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.27150748 |
| 159 | thymic T cell selection (GO:0045061) | 2.26990488 |
| 160 | myofibril assembly (GO:0030239) | 2.26556982 |
| 161 | activation of JUN kinase activity (GO:0007257) | 2.26345631 |
| 162 | apoptotic process involved in morphogenesis (GO:0060561) | 2.25798031 |
| 163 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.25197082 |
| 164 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.24133187 |
| 165 | regulation of defense response to virus by virus (GO:0050690) | 2.21190568 |
| 166 | positive T cell selection (GO:0043368) | 2.20839688 |
| 167 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.19247058 |
| 168 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.18796918 |
| 169 | cortical actin cytoskeleton organization (GO:0030866) | 2.18348610 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.77793659 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.37563187 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.04546951 |
| 4 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.94181942 |
| 5 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.65205866 |
| 6 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.64723232 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.56508746 |
| 8 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.37858006 |
| 9 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.34283850 |
| 10 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.31834696 |
| 11 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.29399650 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.23674661 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.07992365 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.07468219 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.01125234 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.00667341 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96391444 |
| 18 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94219480 |
| 19 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.93964811 |
| 20 | KDM2B_26808549_Chip-Seq_K562_Human | 1.90718214 |
| 21 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.87412184 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.86456863 |
| 23 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.83434382 |
| 24 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.81693075 |
| 25 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.77204526 |
| 26 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.76203931 |
| 27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.75091789 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70788167 |
| 29 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.66536963 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.65063349 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.64063917 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61993964 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.58847859 |
| 34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.55240828 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.55047760 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52201196 |
| 37 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.51650056 |
| 38 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51331966 |
| 39 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.51305028 |
| 40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.50960873 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50437698 |
| 42 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.49862590 |
| 43 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48979282 |
| 44 | ATF3_27146783_Chip-Seq_COLON_Human | 1.48382956 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46773469 |
| 46 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.46053311 |
| 47 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.46053311 |
| 48 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.45494159 |
| 49 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44826814 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44657730 |
| 51 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44200368 |
| 52 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.44059889 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40900892 |
| 54 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39248517 |
| 55 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.38802100 |
| 56 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.38103225 |
| 57 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.38045768 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.37293037 |
| 59 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.35919827 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.35882896 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35310687 |
| 62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33838874 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32098362 |
| 64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.31418887 |
| 65 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.31142836 |
| 66 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27200012 |
| 67 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27187605 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26067835 |
| 69 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24736267 |
| 70 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.23178786 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22716170 |
| 72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22440681 |
| 73 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22192855 |
| 74 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22092539 |
| 75 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21647394 |
| 76 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21521430 |
| 77 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20337294 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19485458 |
| 79 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18578338 |
| 80 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18277938 |
| 81 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.17681377 |
| 82 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17494593 |
| 83 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16159458 |
| 84 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15551991 |
| 85 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.15505379 |
| 86 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.14228951 |
| 87 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.13934307 |
| 88 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13422778 |
| 89 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.12376935 |
| 90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12139383 |
| 91 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11636606 |
| 92 | SPI1_23127762_ChIP-Seq_K562_Human | 1.11579689 |
| 93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09645737 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09168880 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09132537 |
| 96 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08911491 |
| 97 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.08076363 |
| 98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07848170 |
| 99 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.07521061 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06943385 |
| 101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06771704 |
| 102 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06137562 |
| 103 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.05981593 |
| 104 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05788425 |
| 105 | MAF_26560356_Chip-Seq_TH2_Human | 1.05390110 |
| 106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04764018 |
| 107 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.04524362 |
| 108 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03924725 |
| 109 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03822553 |
| 110 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.02556003 |
| 111 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.02451910 |
| 112 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01385849 |
| 113 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00880406 |
| 114 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00613312 |
| 115 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.99803593 |
| 116 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99404957 |
| 117 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99043793 |
| 118 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97878938 |
| 119 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97771960 |
| 120 | MYB_26560356_Chip-Seq_TH1_Human | 0.97636650 |
| 121 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.97557676 |
| 122 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96332317 |
| 123 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95807201 |
| 124 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95011872 |
| 125 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.93247497 |
| 126 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.93073605 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 4.18112405 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.96934514 |
| 3 | MP0005058_abnormal_lysosome_morphology | 2.71161463 |
| 4 | MP0005076_abnormal_cell_differentiation | 2.66840498 |
| 5 | MP0003436_decreased_susceptibility_to | 2.61121670 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.60770702 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.60503723 |
| 8 | MP0008961_abnormal_basal_metabolism | 2.51310460 |
| 9 | MP0008260_abnormal_autophagy | 2.51155563 |
| 10 | MP0009278_abnormal_bone_marrow | 2.39526671 |
| 11 | MP0000751_myopathy | 2.37970369 |
| 12 | MP0004084_abnormal_cardiac_muscle | 2.27621378 |
| 13 | MP0005670_abnormal_white_adipose | 2.19985316 |
| 14 | MP0003566_abnormal_cell_adhesion | 2.13736557 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 2.08380958 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.04342626 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.03923147 |
| 18 | MP0004130_abnormal_muscle_cell | 2.00454276 |
| 19 | MP0000733_abnormal_muscle_development | 1.95844416 |
| 20 | MP0005666_abnormal_adipose_tissue | 1.94952780 |
| 21 | MP0003763_abnormal_thymus_physiology | 1.94078609 |
| 22 | MP0004087_abnormal_muscle_fiber | 1.91564559 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 1.89123980 |
| 24 | MP0003646_muscle_fatigue | 1.88237994 |
| 25 | MP0003045_fibrosis | 1.85217131 |
| 26 | MP0002877_abnormal_melanocyte_morpholog | 1.80049952 |
| 27 | MP0010630_abnormal_cardiac_muscle | 1.74473901 |
| 28 | MP0010307_abnormal_tumor_latency | 1.70218854 |
| 29 | MP0005409_darkened_coat_color | 1.66097648 |
| 30 | MP0001849_ear_inflammation | 1.65303513 |
| 31 | MP0005375_adipose_tissue_phenotype | 1.64840956 |
| 32 | MP0002269_muscular_atrophy | 1.61040349 |
| 33 | MP0004510_myositis | 1.59350392 |
| 34 | MP0004036_abnormal_muscle_relaxation | 1.58632275 |
| 35 | MP0002396_abnormal_hematopoietic_system | 1.52182528 |
| 36 | MP0004233_abnormal_muscle_weight | 1.48396603 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.42113764 |
| 38 | MP0003828_pulmonary_edema | 1.41368384 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.41354574 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.41337889 |
| 41 | MP0002419_abnormal_innate_immunity | 1.39807220 |
| 42 | MP0000003_abnormal_adipose_tissue | 1.37587532 |
| 43 | MP0002009_preneoplasia | 1.37062592 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.36760489 |
| 45 | MP0003283_abnormal_digestive_organ | 1.36320780 |
| 46 | MP0000858_altered_metastatic_potential | 1.34256219 |
| 47 | MP0002653_abnormal_ependyma_morphology | 1.34096340 |
| 48 | MP0000747_muscle_weakness | 1.33354227 |
| 49 | MP0001835_abnormal_antigen_presentation | 1.32067757 |
| 50 | MP0002106_abnormal_muscle_physiology | 1.31592726 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.31257348 |
| 52 | MP0005025_abnormal_response_to | 1.30715902 |
| 53 | MP0001348_abnormal_lacrimal_gland | 1.30139420 |
| 54 | MP0003303_peritoneal_inflammation | 1.28040292 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.27988146 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.24133816 |
| 57 | MP0004197_abnormal_fetal_growth/weight/ | 1.23017035 |
| 58 | MP0003329_amyloid_beta_deposits | 1.22866269 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 1.22780732 |
| 60 | MP0005330_cardiomyopathy | 1.22677768 |
| 61 | MP0000759_abnormal_skeletal_muscle | 1.20734486 |
| 62 | MP0005623_abnormal_meninges_morphology | 1.20554760 |
| 63 | MP0004381_abnormal_hair_follicle | 1.18684340 |
| 64 | MP0008995_early_reproductive_senescence | 1.14862517 |
| 65 | MP0001800_abnormal_humoral_immune | 1.14279916 |
| 66 | MP0005377_hearing/vestibular/ear_phenot | 1.14223497 |
| 67 | MP0003878_abnormal_ear_physiology | 1.14223497 |
| 68 | MP0003091_abnormal_cell_migration | 1.13113300 |
| 69 | MP0005387_immune_system_phenotype | 1.12589357 |
| 70 | MP0001790_abnormal_immune_system | 1.12589357 |
| 71 | MP0002398_abnormal_bone_marrow | 1.12085210 |
| 72 | MP0002909_abnormal_adrenal_gland | 1.11932133 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.11563166 |
| 74 | MP0000703_abnormal_thymus_morphology | 1.10705446 |
| 75 | MP0000749_muscle_degeneration | 1.10329834 |
| 76 | MP0003252_abnormal_bile_duct | 1.10310127 |
| 77 | MP0003115_abnormal_respiratory_system | 1.10162741 |
| 78 | MP0003656_abnormal_erythrocyte_physiolo | 1.09040753 |
| 79 | MP0001545_abnormal_hematopoietic_system | 1.08898475 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 1.08898475 |
| 81 | MP0009672_abnormal_birth_weight | 1.08492226 |
| 82 | MP0001730_embryonic_growth_arrest | 1.08170537 |
| 83 | MP0002088_abnormal_embryonic_growth/wei | 1.07927388 |
| 84 | MP0003984_embryonic_growth_retardation | 1.07740368 |
| 85 | MP0000266_abnormal_heart_morphology | 1.07573406 |
| 86 | MP0005023_abnormal_wound_healing | 1.07411360 |
| 87 | MP0003724_increased_susceptibility_to | 1.06623518 |
| 88 | MP0002420_abnormal_adaptive_immunity | 1.06471414 |
| 89 | MP0001819_abnormal_immune_cell | 1.05799061 |
| 90 | MP0003279_aneurysm | 1.05341156 |
| 91 | MP0002086_abnormal_extraembryonic_tissu | 1.04185429 |
| 92 | MP0005464_abnormal_platelet_physiology | 1.03990899 |
| 93 | MP0006138_congestive_heart_failure | 1.03343002 |
| 94 | MP0005380_embryogenesis_phenotype | 1.02805839 |
| 95 | MP0001672_abnormal_embryogenesis/_devel | 1.02805839 |
| 96 | MP0004145_abnormal_muscle_electrophysio | 1.02595705 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 1.02217185 |
| 98 | MP0001533_abnormal_skeleton_physiology | 1.02097093 |
| 99 | MP0002723_abnormal_immune_serum | 1.01408168 |
| 100 | MP0002452_abnormal_antigen_presenting | 0.99710764 |
| 101 | MP0000537_abnormal_urethra_morphology | 0.98277071 |
| 102 | MP0002925_abnormal_cardiovascular_devel | 0.98236878 |
| 103 | MP0005621_abnormal_cell_physiology | 0.97527386 |
| 104 | MP0002084_abnormal_developmental_patter | 0.96105064 |
| 105 | MP0005369_muscle_phenotype | 0.95520354 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.94076274 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.93680622 |
| 108 | MP0001544_abnormal_cardiovascular_syste | 0.92684404 |
| 109 | MP0005385_cardiovascular_system_phenoty | 0.92684404 |
| 110 | MP0002722_abnormal_immune_system | 0.92599060 |
| 111 | MP0001915_intracranial_hemorrhage | 0.92427303 |
| 112 | MP0004858_abnormal_nervous_system | 0.92202322 |
| 113 | MP0000716_abnormal_immune_system | 0.91693348 |
| 114 | MP0003183_abnormal_peptide_metabolism | 0.91479798 |
| 115 | MP0009840_abnormal_foam_cell | 0.91415301 |
| 116 | MP0002405_respiratory_system_inflammati | 0.89483132 |
| 117 | MP0003690_abnormal_glial_cell | 0.89142854 |
| 118 | MP0000678_abnormal_parathyroid_gland | 0.88969791 |
| 119 | MP0005275_abnormal_skin_tensile | 0.87839291 |
| 120 | MP0003111_abnormal_nucleus_morphology | 0.86613861 |
| 121 | MP0001851_eye_inflammation | 0.86093082 |
| 122 | MP0002429_abnormal_blood_cell | 0.84801245 |
| 123 | MP0004947_skin_inflammation | 0.84706881 |
| 124 | MP0002971_abnormal_brown_adipose | 0.84351413 |
| 125 | MP0000609_abnormal_liver_physiology | 0.83915536 |
| 126 | MP0002089_abnormal_postnatal_growth/wei | 0.81285769 |
| 127 | MP0001958_emphysema | 0.81282291 |
| 128 | MP0009780_abnormal_chondrocyte_physiolo | 0.80321859 |
| 129 | MP0000350_abnormal_cell_proliferation | 0.80197272 |
| 130 | MP0005620_abnormal_muscle_contractility | 0.79738938 |
| 131 | MP0002796_impaired_skin_barrier | 0.79734631 |
| 132 | MP0000604_amyloidosis | 0.79639305 |
| 133 | MP0008770_decreased_survivor_rate | 0.79606397 |
| 134 | MP0000428_abnormal_craniofacial_morphol | 0.79456919 |
| 135 | MP0002928_abnormal_bile_duct | 0.78898291 |
| 136 | MP0004264_abnormal_extraembryonic_tissu | 0.78822236 |
| 137 | MP0002080_prenatal_lethality | 0.78754667 |
| 138 | MP0002234_abnormal_pharynx_morphology | 0.78343708 |
| 139 | MP0000685_abnormal_immune_system | 0.78306398 |
| 140 | MP0002085_abnormal_embryonic_tissue | 0.78197712 |
| 141 | MP0002166_altered_tumor_susceptibility | 0.77792103 |
| 142 | MP0000371_diluted_coat_color | 0.77718735 |
| 143 | MP0003787_abnormal_imprinting | 0.76820068 |
| 144 | MP0002128_abnormal_blood_circulation | 0.76724672 |
| 145 | MP0008775_abnormal_heart_ventricle | 0.76207023 |
| 146 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76131303 |
| 147 | MP0009703_decreased_birth_body | 0.76052977 |
| 148 | MP0001697_abnormal_embryo_size | 0.75972740 |
| 149 | MP0003075_altered_response_to | 0.75351613 |
| 150 | MP0003567_abnormal_fetal_cardiomyocyte | 0.74303109 |
| 151 | MP0000689_abnormal_spleen_morphology | 0.73989973 |
| 152 | MP0005671_abnormal_response_to | 0.71285361 |
| 153 | MP0000490_abnormal_crypts_of | 0.70680904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral aneurysm (HP:0004944) | 3.97912958 |
| 2 | Hyperacusis (HP:0010780) | 3.73191672 |
| 3 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.43344569 |
| 4 | Eczematoid dermatitis (HP:0000976) | 3.13963600 |
| 5 | Distal upper limb amyotrophy (HP:0007149) | 3.13589743 |
| 6 | Upper limb amyotrophy (HP:0009129) | 3.13589743 |
| 7 | Difficulty running (HP:0009046) | 3.12798202 |
| 8 | Increased connective tissue (HP:0009025) | 3.04665055 |
| 9 | Hand muscle atrophy (HP:0009130) | 3.03822437 |
| 10 | Abnormality of the lower motor neuron (HP:0002366) | 2.98032533 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 2.96533420 |
| 12 | Enlarged penis (HP:0000040) | 2.86190831 |
| 13 | Elfin facies (HP:0004428) | 2.80859340 |
| 14 | Macroorchidism (HP:0000053) | 2.79572801 |
| 15 | Aneurysm (HP:0002617) | 2.73898256 |
| 16 | Ankle contracture (HP:0006466) | 2.70054491 |
| 17 | Broad face (HP:0000283) | 2.69273196 |
| 18 | Renovascular hypertension (HP:0100817) | 2.67797252 |
| 19 | Abnormality of the fingertips (HP:0001211) | 2.67046800 |
| 20 | Dysmetric saccades (HP:0000641) | 2.66550456 |
| 21 | Difficulty climbing stairs (HP:0003551) | 2.60417213 |
| 22 | Exercise-induced myalgia (HP:0003738) | 2.59831033 |
| 23 | Obstructive sleep apnea (HP:0002870) | 2.59486859 |
| 24 | Shallow orbits (HP:0000586) | 2.58825787 |
| 25 | Aortic aneurysm (HP:0004942) | 2.58417764 |
| 26 | Type 1 muscle fiber predominance (HP:0003803) | 2.57951263 |
| 27 | Distal lower limb muscle weakness (HP:0009053) | 2.53421885 |
| 28 | Broad metatarsal (HP:0001783) | 2.51782417 |
| 29 | Bundle branch block (HP:0011710) | 2.50006479 |
| 30 | Muscle fiber inclusion bodies (HP:0100299) | 2.43125328 |
| 31 | Insomnia (HP:0100785) | 2.40069028 |
| 32 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.36238863 |
| 33 | Long toe (HP:0010511) | 2.33396471 |
| 34 | Cellulitis (HP:0100658) | 2.33128128 |
| 35 | Nemaline bodies (HP:0003798) | 2.31203503 |
| 36 | Heterotopia (HP:0002282) | 2.30814043 |
| 37 | Protrusio acetabuli (HP:0003179) | 2.30680195 |
| 38 | Exercise-induced muscle cramps (HP:0003710) | 2.27840355 |
| 39 | Colitis (HP:0002583) | 2.27743028 |
| 40 | Lymphangioma (HP:0100764) | 2.27578191 |
| 41 | Asymmetric septal hypertrophy (HP:0001670) | 2.26763300 |
| 42 | Bladder diverticulum (HP:0000015) | 2.25441290 |
| 43 | Bowel diverticulosis (HP:0005222) | 2.24777919 |
| 44 | Ependymoma (HP:0002888) | 2.23014754 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.22243878 |
| 46 | Facial diplegia (HP:0001349) | 2.22226885 |
| 47 | Renal duplication (HP:0000075) | 2.20498431 |
| 48 | Rectal prolapse (HP:0002035) | 2.18738955 |
| 49 | EMG: neuropathic changes (HP:0003445) | 2.17462730 |
| 50 | Frequent falls (HP:0002359) | 2.15812135 |
| 51 | Mitral valve prolapse (HP:0001634) | 2.15501087 |
| 52 | Muscle fiber splitting (HP:0003555) | 2.10997957 |
| 53 | Flat acetabular roof (HP:0003180) | 2.10661153 |
| 54 | Increased variability in muscle fiber diameter (HP:0003557) | 2.09613727 |
| 55 | Myoglobinuria (HP:0002913) | 2.09576891 |
| 56 | Sudden death (HP:0001699) | 2.09211239 |
| 57 | Right ventricular cardiomyopathy (HP:0011663) | 2.07381339 |
| 58 | Male infertility (HP:0003251) | 2.04023070 |
| 59 | Pointed chin (HP:0000307) | 2.03955371 |
| 60 | Back pain (HP:0003418) | 2.03889077 |
| 61 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.01954942 |
| 62 | Subaortic stenosis (HP:0001682) | 2.01954942 |
| 63 | EMG: myopathic abnormalities (HP:0003458) | 2.00980223 |
| 64 | Astrocytoma (HP:0009592) | 1.99320315 |
| 65 | Abnormality of the astrocytes (HP:0100707) | 1.99320315 |
| 66 | Ulnar bowing (HP:0003031) | 1.99294830 |
| 67 | Atrioventricular block (HP:0001678) | 1.98782093 |
| 68 | Overriding aorta (HP:0002623) | 1.98745305 |
| 69 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.98653205 |
| 70 | Gingivitis (HP:0000230) | 1.98639118 |
| 71 | Pseudobulbar signs (HP:0002200) | 1.97772571 |
| 72 | Increased IgE level (HP:0003212) | 1.96264967 |
| 73 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.95153848 |
| 74 | Flat cornea (HP:0007720) | 1.95152326 |
| 75 | Fatigue (HP:0012378) | 1.94865043 |
| 76 | Recurrent abscess formation (HP:0002722) | 1.94751288 |
| 77 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.94692156 |
| 78 | Neoplasm of the heart (HP:0100544) | 1.92275551 |
| 79 | Abnormality of the Achilles tendon (HP:0005109) | 1.91111137 |
| 80 | Striae distensae (HP:0001065) | 1.90385871 |
| 81 | Dilatation of the ascending aorta (HP:0005111) | 1.89928929 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 1.88529540 |
| 83 | Hemorrhage of the eye (HP:0011885) | 1.88488737 |
| 84 | Ventricular tachycardia (HP:0004756) | 1.88224620 |
| 85 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.87690068 |
| 86 | Scapular winging (HP:0003691) | 1.87577877 |
| 87 | Recurrent bacterial skin infections (HP:0005406) | 1.86286160 |
| 88 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.85948218 |
| 89 | Reticulocytosis (HP:0001923) | 1.84072668 |
| 90 | Metaphyseal cupping (HP:0003021) | 1.82828105 |
| 91 | Abnormality of macrophages (HP:0004311) | 1.82733310 |
| 92 | Round ear (HP:0100830) | 1.82098761 |
| 93 | High pitched voice (HP:0001620) | 1.82051054 |
| 94 | Short 4th metacarpal (HP:0010044) | 1.81450198 |
| 95 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.81450198 |
| 96 | Subacute progressive viral hepatitis (HP:0006572) | 1.81380992 |
| 97 | Ulnar deviation of the wrist (HP:0003049) | 1.81244435 |
| 98 | Abnormality of the thoracic spine (HP:0100711) | 1.81084089 |
| 99 | Interstitial pulmonary disease (HP:0006530) | 1.80263249 |
| 100 | Long palpebral fissure (HP:0000637) | 1.80199638 |
| 101 | Increased density of long bones (HP:0006392) | 1.80180098 |
| 102 | Abnormality of the 4th metacarpal (HP:0010012) | 1.79846478 |
| 103 | Ragged-red muscle fibers (HP:0003200) | 1.79079086 |
| 104 | Rhabdomyolysis (HP:0003201) | 1.78531383 |
| 105 | Gastrointestinal infarctions (HP:0005244) | 1.77920952 |
| 106 | Gastrointestinal stroma tumor (HP:0100723) | 1.77885131 |
| 107 | Dislocated radial head (HP:0003083) | 1.77850063 |
| 108 | Narrow palate (HP:0000189) | 1.76744127 |
| 109 | Foot dorsiflexor weakness (HP:0009027) | 1.76245013 |
| 110 | Slow saccadic eye movements (HP:0000514) | 1.76175760 |
| 111 | Hypercortisolism (HP:0001578) | 1.76095621 |
| 112 | Vertebral arch anomaly (HP:0008438) | 1.73057312 |
| 113 | Genu recurvatum (HP:0002816) | 1.72149090 |
| 114 | Myopathic facies (HP:0002058) | 1.71394331 |
| 115 | Progressive external ophthalmoplegia (HP:0000590) | 1.71069412 |
| 116 | Heart block (HP:0012722) | 1.70799919 |
| 117 | Dysostosis multiplex (HP:0000943) | 1.69769448 |
| 118 | Increased nuchal translucency (HP:0010880) | 1.69564271 |
| 119 | Turricephaly (HP:0000262) | 1.69140187 |
| 120 | Progressive muscle weakness (HP:0003323) | 1.68525603 |
| 121 | Thin bony cortex (HP:0002753) | 1.67988170 |
| 122 | Radial bowing (HP:0002986) | 1.67674012 |
| 123 | Aortic dissection (HP:0002647) | 1.66921891 |
| 124 | Onion bulb formation (HP:0003383) | 1.66559042 |
| 125 | Spinal cord lesions (HP:0100561) | 1.66356548 |
| 126 | Syringomyelia (HP:0003396) | 1.66356548 |
| 127 | Abnormal gallbladder physiology (HP:0012438) | 1.65509524 |
| 128 | Cholecystitis (HP:0001082) | 1.65509524 |
| 129 | Long eyelashes (HP:0000527) | 1.65337202 |
| 130 | Ventricular fibrillation (HP:0001663) | 1.64904040 |
| 131 | Spinal rigidity (HP:0003306) | 1.63908752 |
| 132 | Viral hepatitis (HP:0006562) | 1.63905185 |
| 133 | Thoracic kyphosis (HP:0002942) | 1.63523916 |
| 134 | Obsessive-compulsive behavior (HP:0000722) | 1.63279479 |
| 135 | Cerebral inclusion bodies (HP:0100314) | 1.63171929 |
| 136 | Muscle stiffness (HP:0003552) | 1.63114973 |
| 137 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.62820650 |
| 138 | Abnormal atrioventricular conduction (HP:0005150) | 1.62779895 |
| 139 | Hematochezia (HP:0002573) | 1.61565110 |
| 140 | Mitral regurgitation (HP:0001653) | 1.61376850 |
| 141 | Inflammation of the large intestine (HP:0002037) | 1.61165526 |
| 142 | Resting tremor (HP:0002322) | 1.60809631 |
| 143 | Chest pain (HP:0100749) | 1.60471975 |
| 144 | Polycythemia (HP:0001901) | 1.59724399 |
| 145 | Abnormality of the foot musculature (HP:0001436) | 1.59671044 |
| 146 | Germ cell neoplasia (HP:0100728) | 1.59541777 |
| 147 | Distal lower limb amyotrophy (HP:0008944) | 1.59415329 |
| 148 | Cervical subluxation (HP:0003308) | 1.58443109 |
| 149 | Abnormality of the calcaneus (HP:0008364) | 1.58344837 |
| 150 | Stridor (HP:0010307) | 1.58203202 |
| 151 | Proximal amyotrophy (HP:0007126) | 1.58070114 |
| 152 | Abnormality of the radial head (HP:0003995) | 1.57736959 |
| 153 | Bulbar palsy (HP:0001283) | 1.57711303 |
| 154 | Disproportionate tall stature (HP:0001519) | 1.57602665 |
| 155 | Decreased motor nerve conduction velocity (HP:0003431) | 1.57034560 |
| 156 | Mediastinal lymphadenopathy (HP:0100721) | 1.56757665 |
| 157 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.56567978 |
| 158 | Broad palm (HP:0001169) | 1.56472398 |
| 159 | Myositis (HP:0100614) | 1.56382901 |
| 160 | Fibroma (HP:0010614) | 1.55464946 |
| 161 | Deep palmar crease (HP:0006191) | 1.55348139 |
| 162 | Hallux valgus (HP:0001822) | 1.54969138 |
| 163 | Achilles tendon contracture (HP:0001771) | 1.54480469 |
| 164 | Lower limb amyotrophy (HP:0007210) | 1.54322535 |
| 165 | Deviation of the hallux (HP:0010051) | 1.54073934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.92866496 |
| 2 | PRPF4B | 3.87424925 |
| 3 | PKN2 | 3.80608002 |
| 4 | EEF2K | 3.65989822 |
| 5 | SMG1 | 3.35407367 |
| 6 | CDK12 | 3.25522176 |
| 7 | MAP3K10 | 2.97329134 |
| 8 | TTN | 2.92368947 |
| 9 | RIPK1 | 2.55573453 |
| 10 | ERN1 | 2.35968642 |
| 11 | PTK6 | 2.06326854 |
| 12 | SIK1 | 2.06250246 |
| 13 | RIPK4 | 2.00300834 |
| 14 | LATS1 | 1.98914437 |
| 15 | PDGFRA | 1.89997133 |
| 16 | ICK | 1.87595692 |
| 17 | IRAK3 | 1.78435047 |
| 18 | MAP3K13 | 1.59649103 |
| 19 | CAMK1D | 1.56331839 |
| 20 | PRKD3 | 1.53099272 |
| 21 | FGFR4 | 1.44931865 |
| 22 | CAMK1G | 1.42795698 |
| 23 | MTOR | 1.42623951 |
| 24 | TYRO3 | 1.38691483 |
| 25 | TAOK1 | 1.38316227 |
| 26 | MAP3K14 | 1.28535235 |
| 27 | NEK2 | 1.26580926 |
| 28 | EPHB1 | 1.25064537 |
| 29 | ALK | 1.19089791 |
| 30 | MAP3K7 | 1.18086615 |
| 31 | LMTK2 | 1.14032902 |
| 32 | DMPK | 1.12338539 |
| 33 | IRAK4 | 1.11060998 |
| 34 | TAOK2 | 1.10667434 |
| 35 | BRD4 | 1.10100012 |
| 36 | MAP4K1 | 1.08317371 |
| 37 | PAK4 | 1.07984831 |
| 38 | SIK2 | 1.07133542 |
| 39 | FLT3 | 1.04990908 |
| 40 | MAP2K3 | 1.02686487 |
| 41 | BMX | 1.02616969 |
| 42 | MAP3K6 | 1.01737261 |
| 43 | MAPK12 | 0.99502006 |
| 44 | STK38 | 0.98809390 |
| 45 | RET | 0.98209223 |
| 46 | KSR2 | 0.98137259 |
| 47 | MAPKAPK3 | 0.97842542 |
| 48 | CDK4 | 0.96469030 |
| 49 | FGFR3 | 0.96102520 |
| 50 | LATS2 | 0.94204887 |
| 51 | BLK | 0.93595846 |
| 52 | LRRK2 | 0.92424001 |
| 53 | TBK1 | 0.91553968 |
| 54 | PDPK1 | 0.88473604 |
| 55 | PTK2 | 0.87265440 |
| 56 | JAK1 | 0.86672874 |
| 57 | SCYL2 | 0.86599605 |
| 58 | PDK3 | 0.86519447 |
| 59 | PDK4 | 0.86519447 |
| 60 | PDGFRB | 0.86347277 |
| 61 | NEK1 | 0.85461522 |
| 62 | IRAK2 | 0.84177627 |
| 63 | CDK6 | 0.82951500 |
| 64 | STK10 | 0.81365302 |
| 65 | CDC42BPA | 0.80832745 |
| 66 | SIK3 | 0.80732879 |
| 67 | RPS6KB2 | 0.80250459 |
| 68 | PAK2 | 0.79225896 |
| 69 | PRKCH | 0.77946707 |
| 70 | MAP3K11 | 0.77166091 |
| 71 | CAMKK1 | 0.75757678 |
| 72 | STK3 | 0.73736705 |
| 73 | PAK6 | 0.72972289 |
| 74 | SGK3 | 0.71271496 |
| 75 | TNK2 | 0.70614646 |
| 76 | RPS6KL1 | 0.70453254 |
| 77 | RPS6KC1 | 0.70453254 |
| 78 | OBSCN | 0.70077647 |
| 79 | CDK9 | 0.69744584 |
| 80 | TESK2 | 0.67504161 |
| 81 | JAK3 | 0.65259616 |
| 82 | BTK | 0.63967363 |
| 83 | NME2 | 0.62502776 |
| 84 | TAOK3 | 0.62176057 |
| 85 | TYK2 | 0.62157878 |
| 86 | JAK2 | 0.61555503 |
| 87 | FES | 0.59402946 |
| 88 | DDR2 | 0.58597629 |
| 89 | RAF1 | 0.57418929 |
| 90 | PHKG1 | 0.57114000 |
| 91 | PHKG2 | 0.57114000 |
| 92 | MAPK7 | 0.56649767 |
| 93 | PASK | 0.55229621 |
| 94 | MAP2K2 | 0.55218919 |
| 95 | MARK2 | 0.54880046 |
| 96 | EPHA2 | 0.54587742 |
| 97 | ARAF | 0.53454446 |
| 98 | PRKD2 | 0.52957086 |
| 99 | MAP3K8 | 0.52666663 |
| 100 | PRKAA1 | 0.52377051 |
| 101 | DYRK1B | 0.51385503 |
| 102 | FGFR1 | 0.50011694 |
| 103 | MAPK11 | 0.49864922 |
| 104 | CHUK | 0.49448909 |
| 105 | MAP3K9 | 0.49119260 |
| 106 | PRKD1 | 0.48640371 |
| 107 | TGFBR2 | 0.48590318 |
| 108 | WNK1 | 0.47446178 |
| 109 | NEK9 | 0.47125855 |
| 110 | PRKAA2 | 0.45732316 |
| 111 | RPS6KA6 | 0.45723453 |
| 112 | FGR | 0.43911833 |
| 113 | BRAF | 0.43159646 |
| 114 | ZAP70 | 0.42820305 |
| 115 | DAPK2 | 0.42648705 |
| 116 | AKT2 | 0.42453872 |
| 117 | RPS6KA2 | 0.41734976 |
| 118 | MOS | 0.41374797 |
| 119 | CSK | 0.40977976 |
| 120 | GRK6 | 0.40507791 |
| 121 | HCK | 0.40198317 |
| 122 | RPS6KA1 | 0.39034443 |
| 123 | PDK1 | 0.38807489 |
| 124 | KSR1 | 0.38732090 |
| 125 | MAP3K1 | 0.38054528 |
| 126 | CHEK1 | 0.37539899 |
| 127 | IRAK1 | 0.36993995 |
| 128 | STK4 | 0.36844409 |
| 129 | CAMK4 | 0.36697803 |
| 130 | MST1R | 0.35985525 |
| 131 | CDC7 | 0.35158956 |
| 132 | IKBKE | 0.34699714 |
| 133 | BCKDK | 0.33802438 |
| 134 | HIPK2 | 0.33244044 |
| 135 | MARK3 | 0.33150252 |
| 136 | MAP3K3 | 0.32458363 |
| 137 | MAPK8 | 0.32280541 |
| 138 | MAP3K2 | 0.31496456 |
| 139 | MAPK1 | 0.30708295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.31630148 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.28134718 |
| 3 | Lysine degradation_Homo sapiens_hsa00310 | 2.22287253 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.78336218 |
| 5 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.75526236 |
| 6 | Insulin resistance_Homo sapiens_hsa04931 | 1.73248027 |
| 7 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.71349097 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69293041 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52507252 |
| 10 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.47514450 |
| 11 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.45886987 |
| 12 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.44471301 |
| 13 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.43473775 |
| 14 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41620544 |
| 15 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.39561657 |
| 16 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.37907975 |
| 17 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.36271611 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.34054068 |
| 19 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.30895019 |
| 20 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.30570849 |
| 21 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.29382186 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.28845006 |
| 23 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.28777364 |
| 24 | Focal adhesion_Homo sapiens_hsa04510 | 1.28069249 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.24611506 |
| 26 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.23217434 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22498312 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.20864430 |
| 29 | Endometrial cancer_Homo sapiens_hsa05213 | 1.20358693 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19165354 |
| 31 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.19062584 |
| 32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17421230 |
| 33 | Adherens junction_Homo sapiens_hsa04520 | 1.13472814 |
| 34 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.11838514 |
| 35 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.11575296 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.10377397 |
| 37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09081830 |
| 38 | Prion diseases_Homo sapiens_hsa05020 | 1.08131942 |
| 39 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.07960141 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06196822 |
| 41 | Glioma_Homo sapiens_hsa05214 | 1.05431915 |
| 42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04926077 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03967849 |
| 44 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03366247 |
| 45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02485466 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.01806963 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01150937 |
| 48 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.00527737 |
| 49 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.00504059 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99626299 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.99244354 |
| 52 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.98626903 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.98252940 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97742717 |
| 55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97595892 |
| 56 | Measles_Homo sapiens_hsa05162 | 0.97245774 |
| 57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96620435 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 0.96467152 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95086832 |
| 60 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.93477954 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92456308 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91112143 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89868935 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89714484 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.89428859 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.89385777 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.87245542 |
| 68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86698304 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86499866 |
| 70 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84166415 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84065461 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.83710110 |
| 73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.82698784 |
| 74 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.82638627 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82601885 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82281679 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82135005 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.81831379 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.81822737 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81664832 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81155135 |
| 82 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.80456755 |
| 83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79289110 |
| 84 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.78894176 |
| 85 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.78803542 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78025152 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.78006929 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76636590 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.76279896 |
| 90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75290647 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75222072 |
| 92 | Long-term potentiation_Homo sapiens_hsa04720 | 0.74856877 |
| 93 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.74065735 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73869751 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.73478488 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68900727 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.68876182 |
| 98 | Endocytosis_Homo sapiens_hsa04144 | 0.68749546 |
| 99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.67695634 |
| 100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67285977 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.65136651 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.64851032 |
| 103 | Salmonella infection_Homo sapiens_hsa05132 | 0.64634067 |
| 104 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63403993 |
| 105 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63199518 |
| 106 | Malaria_Homo sapiens_hsa05144 | 0.62703780 |
| 107 | Shigellosis_Homo sapiens_hsa05131 | 0.62553427 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62367969 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.62354191 |
| 110 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60485746 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59438231 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.59403983 |
| 113 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.59340167 |
| 114 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58951156 |
| 115 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.57996701 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.57770082 |
| 117 | Circadian rhythm_Homo sapiens_hsa04710 | 0.57495015 |
| 118 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57100497 |
| 119 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.55016925 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.54820167 |
| 121 | Prostate cancer_Homo sapiens_hsa05215 | 0.54502922 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.54323478 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53743503 |
| 124 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53570111 |
| 125 | Apoptosis_Homo sapiens_hsa04210 | 0.53509175 |
| 126 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53106257 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52919693 |
| 128 | Tight junction_Homo sapiens_hsa04530 | 0.52617608 |
| 129 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.51990787 |
| 130 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51833307 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51642676 |
| 132 | Hepatitis B_Homo sapiens_hsa05161 | 0.50850932 |
| 133 | Influenza A_Homo sapiens_hsa05164 | 0.50252327 |

